# A Randomized Trial of Botulinum Toxin A vs Strabismus Surgery for Esotropia >10 to ≤30PD

> **NCT07470164** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Jaeb Center for Health Research** · enrollment: 244 (estimated)

## Conditions studied

- Esotropia

## Interventions

- **DRUG:** Botulinum toxin A
- **PROCEDURE:** bilateral medial rectus recession

## Key facts

- **NCT ID:** NCT07470164
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 244 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07470164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07470164, "A Randomized Trial of Botulinum Toxin A vs Strabismus Surgery for Esotropia >10 to ≤30PD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07470164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*